Skip to content

Effect of Extract zataria multiflora on controlling the symptoms of Prennial Allergic Rhinitis

Clinical trial to evaluate the effect of Extract zataria multiflora on clinical sign in Prennial Allergic Rhinitis compared with placebo

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016121823235N6
Enrollment
40
Registered
2017-03-28
Start date
2014-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perennial allergic rhinitis. Other allergic rhinitis

Interventions

Intervention 1: In Intervention group Thyme Syrup extract give three times a day 150 mg (10 cc) for two month with normal treatment of rhinits. Intervention 2: In control group placebo give once a d
Treatment - Drugs
Placebo
In Intervention group Thyme Syrup extract give three times a day 150 mg (10 cc) for two month with normal treatment of rhinits
In control group placebo give once a day for two month with normal treatment of rhinitis

Sponsors

Vice Chancellor for Research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:approved clinical perennial allergic rhinitis and laboratory diagnosis;the desire of patients to drug treatment and participation in the project Exclusion criteria: The risk of other causes of rhinitis; affected of systemic diseases; take any other medicines with antioxidant properties; taking anti-inflammatory drug ; taking any herbal medicine; Thyme intolerance side effects (nausea, vomiting, diarrhea, etc.); Pregnancy and lactation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Clinical symptoms of allergic rhinitis. Timepoint: After two month. Method of measurement: questionnaire.

Secondary

MeasureTime frame
Added at 2017-10-31: IL-4 & IL-5 & ?INF. Timepoint: Added at 2017-10-31: After the intervention. Method of measurement: Added at 2017-10-31: Eliza.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Paanahi

Mashad Universityof Medcal Sciences

arc@mums.ac.ir+98 518012770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 13, 2026